KHPG(SZ:002773) Xin Lang Cai Jing·2025-11-04 02:59Group 1 - The core point of the news is that Kanghong Pharmaceutical experienced a decline of 5.01% in its stock price, reaching 31.46 CNY per share, with a trading volume of 231 million CNY and a turnover rate of 1.05%, resulting in a total market capitalization of 28.985 billion CNY [1] - Kanghong Pharmaceutical, established on October 3, 1996, and listed on June 26, 2015, is based in Chengdu, Sichuan Province, and its main business involves the research, production, and sales of chemical drugs, traditional Chinese medicine, and biological products [1] - The revenue composition of Kanghong Pharmaceutical is as follows: biological drugs account for 54.83%, traditional Chinese medicine 32.49%, chemical drugs 12.50%, and other categories 0.15% [1] Group 2 - Morgan Fund has a significant holding in Kanghong Pharmaceutical, with the Morgan Healthcare Stock A fund (001766) holding 509,000 shares, representing 3.43% of the fund's net value, making it the tenth largest holding [2] - The Morgan Healthcare Stock A fund was established on October 21, 2015, with a current size of 545 million CNY, and has achieved a year-to-date return of 27.08%, ranking 2118 out of 4216 in its category [2] - The fund manager, Ye Min, has been in charge for 3 years and 102 days, with the fund's total assets amounting to 1.861 billion CNY, achieving the best return of 40.74% and the worst return of -5.8% during his tenure [2]